Helena Providelli de Moraes
Mesa Tratamento da Enxaqueca - Sala 3
| Artigo | Autor(es) | Referência |
|---|---|---|
| Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies. | Aurora Sheena K, Brin Mitchell F | Headache. 2017 Jan; 57(Jan):109-125. doi: 10.1111/head.12999. pii: . |
| Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data. | Dodick David W, Silberstein Stephen D, Lipton Richard B, DeGryse Ronald E, Adams Aubrey Manack, Diener Hans-Christoph | Cephalalgia : an international journal of headache. 2019 Jul; 39(Jul):945-956. doi: 10.1177/0333102418825382. pii: . |
| Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine. | Ament Michael, Day Kathleen, Stauffer Virginia L, Skljarevski Vladimir, Rettiganti Mallikarjuna, Pearlman Eric, Aurora Sheena K | The journal of headache and pain. 2021 Feb; 22(Feb):6. doi: 10.1186/s10194-021-01215-9. pii: . |
| Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2. | Lipton Richard B, Goadsby Peter J, Smith Jeff, Schaeffler Barbara A, Biondi David M, Hirman Joe, Pederson Susan, Allan Brent, Cady Roger | Neurology. 2020 03; 94(03):e1365-e1377. doi: 10.1212/WNL.0000000000009169. pii: . |
| Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention. | Lipton Richard B, Silberstein Stephen D | Headache. 2015 Mar; 55 Suppl 2(Mar):103-22; quiz 123-6. doi: 10.1111/head.12505_2. pii: . |
| Exercise in Treatment of Migraine Including Chronic Migraine. | Song Tae-Jin, Chu Min Kyung | Current pain and headache reports. 2021 Feb; 25(Feb):14. doi: 10.1007/s11916-020-00929-w. pii: . |
| Fremanezumab for the Preventive Treatment of Chronic Migraine. | Silberstein Stephen D, Dodick David W, Bigal Marcelo E, Yeung Paul P, Goadsby Peter J, Blankenbiller Tricia, Grozinski-Wolff Melissa, Yang Ronghua, Ma Yuju, Aycardi Ernesto | The New England journal of medicine. 2017 11; 377(11):2113-2122. doi: 10.1056/NEJMoa1709038. pii: . |
| Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study. | Detke Holland C, Goadsby Peter J, Wang Shufang, Friedman Deborah I, Selzler Katherine J, Aurora Sheena K | Neurology. 2018 12; 91(12):e2211-e2221. doi: 10.1212/WNL.0000000000006640. pii: . |
| Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults. | Tassorelli Cristina, Diener Hans-Christoph, Dodick David W, Silberstein Stephen D, Lipton Richard B, Ashina Messoud, Becker Werner J, Ferrari Michel D, Goadsby Peter J, Pozo-Rosich Patricia, Wang Shuu-Jiun, | Cephalalgia : an international journal of headache. 2018 04; 38(04):815-832. doi: 10.1177/0333102418758283. pii: . |
| Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial. | Schwedt Todd J, Hentz Joseph G, Sahai-Srivastava Soma, Spare Nicole M, Martin Vincent T, Treppendahl Christina, Digre Kathleen, Bennett Nathan L, Birlea Marius, Watson David, Murinova Natalia, Robert Teri, Dodick David W, | Headache. 2021 02; 61(02):351-362. doi: 10.1111/head.14056. pii: . |
| How does the brain change in chronic migraine? Developing disease biomarkers. | Pozo-Rosich Patricia, Coppola Gianluca, Pascual Julio, Schwedt Todd J | Cephalalgia : an international journal of headache. 2021 04; 41(04):613-630. doi: 10.1177/0333102420974359. pii: . |
| Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial. | Kudrow David, Cady Roger K, Allan Brent, Pederson Susan M, Hirman Joe, Mehta Lahar R, Schaeffler Barbara A | BMC neurology. 2021 Mar; 21(Mar):126. doi: 10.1186/s12883-021-02123-w. pii: . |
| Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study. | Blumenfeld Andrew M, Stark Richard J, Freeman Marshall C, Orejudos Amelia, Manack Adams Aubrey | The journal of headache and pain. 2018 Feb; 19(Feb):13. doi: 10.1186/s10194-018-0840-8. pii: . |
| Migraine Progression: A Systematic Review. | Buse Dawn C, Greisman Jacob D, Baigi Khosrow, Lipton Richard B | Headache. 2019 03; 59(03):306-338. doi: 10.1111/head.13459. pii: . |
| Multisensorial Perception in Chronic Migraine and the Role of Medication Overuse. | Maccora Simona, Bolognini Nadia, Cosentino Giuseppe, Baschi Roberta, Vallar Giuseppe, Fierro Brigida, Brighina Filippo | The journal of pain. 21():919-929. doi: 10.1016/j.jpain.2019.12.005. pii: S1526-5900(19)30882-X. |
| OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. | Aurora S K, Dodick D W, Turkel C C, DeGryse R E, Silberstein S D, Lipton R B, Diener H C, Brin M F, | Cephalalgia : an international journal of headache. 2010 Jul; 30(Jul):793-803. doi: 10.1177/0333102410364676. pii: . |
| OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. | Diener H C, Dodick D W, Aurora S K, Turkel C C, DeGryse R E, Lipton R B, Silberstein S D, Brin M F, | Cephalalgia : an international journal of headache. 2010 Jul; 30(Jul):804-14. doi: 10.1177/0333102410364677. pii: . |
| OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine. | Frampton James E, Silberstein Stephen | Drugs. 2018 Apr; 78(Apr):589-600. doi: 10.1007/s40265-018-0894-6. pii: . |
| Pathophysiological targets for non-pharmacological treatment of migraine. | Coppola Gianluca, Di Lorenzo Cherubino, Serrao Mariano, Parisi Vincenzo, Schoenen Jean, Pierelli Francesco | Cephalalgia : an international journal of headache. 2016 Oct; 36(Oct):1103-1111. doi: 10.1177/0333102415620908. pii: . |
| Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. | Tepper Stewart, Ashina Messoud, Reuter Uwe, Brandes Jan L, Doležil David, Silberstein Stephen, Winner Paul, Leonardi Dean, Mikol Daniel, Lenz Robert | The Lancet. Neurology. 2017 06; 16(06):425-434. doi: 10.1016/S1474-4422(17)30083-2. pii: S1474-4422(17)30083-2. |
| The Adaptation of Management of Chronic Migraine Patients With Medication Overuse to the Suspension of Treatment Protocols During the COVID-19 Pandemic: Lessons From a Tertiary Headache Center in Milan, Italy. | Grazzi Licia, Rizzoli Paul | Headache. 2020 07; 60(07):1463-1464. doi: 10.1111/head.13825. pii: . |
| What future for treatment of chronic migraine with medication overuse? | Grazzi Licia, Bussone G | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2011 May; 32 Suppl 1(May):S19-22. doi: 10.1007/s10072-011-0553-0. pii: . |
| [Pain catastrophizing and medication overuse in patients with chronic migraine]. | Barral E, Buonanotte F | Revista de neurologia. 2020 Apr; 70(Apr):282-286. doi: 10.33588/rn.7008.2020034. pii: . |